We provide a range of bespoke services dependent on your needs and requirements

The best time to seek advice will vary for different technologies. Typically we provide advice before phase 3 trials begin.

If your technology is in the later stages of development, please contact us to discuss your requirements.

Our advice services

Scientific advice

Detailed advice from NICE and a panel of appointed experts.

Advice for small and medium-sized companies

A concise version of our scientific advice process.

Parallel and joint advice services

European Early Dialogues

Advice from NICE, the European Medicines Agency (EMA) and various other European Health Technology Assessment bodies (HTABs).

NICE-MHRA scientific advice

Joint regulatory advice from the Medicines and Healthcare products Regulatory Agency and NICE.